当前位置:首页 - 行情中心 - 晨光生物(300138) - 财务分析 - 现金流量表

晨光生物

(300138)

  

流通市值:54.05亿  总市值:65.56亿
流通股本:3.98亿   总股本:4.83亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金5,260,619,409.23,952,480,341.221,817,655,715.387,591,161,036.98
  收到的税费返还108,310,353.96107,000,632.1567,535,729.33102,921,119.7
  收到其他与经营活动有关的现金136,570,606.9438,985,879.2433,405,513.7184,659,672.63
  经营活动现金流入小计5,505,500,370.14,098,466,852.611,918,596,958.417,878,741,829.31
  购买商品、接受劳务支付的现金2,764,527,990.552,007,927,012.731,233,677,978.337,568,768,067.6
  支付给职工以及为职工支付的现金199,120,296.94129,978,141.664,956,734.38252,264,199.61
  支付的各项税费78,382,058.9159,416,285.8129,982,725.2110,179,820.28
  支付其他与经营活动有关的现金126,910,294.7971,408,773.1359,535,112.53170,344,701.79
  经营活动现金流出小计3,168,940,641.192,268,730,213.271,388,152,550.448,101,556,789.28
  经营活动产生的现金流量净额2,336,559,728.911,829,736,639.34530,444,407.97-222,814,959.97
二、投资活动产生的现金流量:
  收回投资收到的现金3,564,165,891.41,755,275,796.41,084,403,155.61,021,788,639.79
  取得投资收益收到的现金52,109,337.2833,969,630.049,683,526.8238,572,939.83
  处置固定资产、无形资产和其他长期资产收回的现金净额4,478,3824,381,729.224,402,32016,655.53
  投资活动现金流入小计3,620,753,610.681,793,627,155.661,098,489,002.421,060,378,235.15
  购建固定资产、无形资产和其他长期资产支付的现金93,486,973.0455,852,452.9825,054,833.31149,537,086.88
  投资支付的现金3,813,357,722.033,060,619,929.272,550,042,486.951,337,369,151.29
  支付其他与投资活动有关的现金---14,426,983.15
  投资活动现金流出小计3,906,844,695.073,116,472,382.252,575,097,320.261,501,333,221.32
  投资活动产生的现金流量净额-286,091,084.39-1,322,845,226.59-1,476,608,317.84-440,954,986.17
三、筹资活动产生的现金流量:
  取得借款收到的现金1,789,690,035.91,965,690,035.91,505,278,154.265,783,439,209.46
  筹资活动现金流入小计1,789,690,035.91,965,690,035.91,505,278,154.265,783,439,209.46
  偿还债务支付的现金2,878,667,225.161,603,829,488.96311,000,0005,087,427,959
  分配股利、利润或偿付利息支付的现金138,353,989.85125,010,139.424,287,014.63174,848,426.65
  其中:子公司支付给少数股东的股利、利润---793,517.8
  支付其他与筹资活动有关的现金1,696,626.491,693,835-417,362,455.29
  筹资活动现金流出小计3,018,717,841.51,730,533,463.36335,287,014.635,679,638,840.94
  筹资活动产生的现金流量净额-1,229,027,805.6235,156,572.541,169,991,139.63103,800,368.52
四、汇率变动对现金及现金等价物的影响-4,979,642.25-2,226,398.82-2,338,013.84-10,493,145.08
五、现金及现金等价物净增加额816,461,196.67739,821,586.47221,489,215.92-570,462,722.7
  加:期初现金及现金等价物余额514,802,240.02514,802,240.02514,802,240.021,085,264,962.72
  期末现金及现金等价物余额1,331,263,436.691,254,623,826.49736,291,455.94514,802,240.02
补充资料:
  净利润-221,253,745.12-77,957,113.49
  资产减值准备-13,183,693.56-95,164,207.13
  固定资产和投资性房地产折旧-84,586,334.61-157,696,415.82
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-84,586,334.61-157,696,415.82
  无形资产摊销-4,817,267.04-8,969,905.84
  长期待摊费用摊销-100,000.02-200,000.04
  处置固定资产、无形资产和其他长期资产的损失--3,982,574.33--4,887,839.58
  固定资产报废损失-48,622.16-457,881.85
  公允价值变动损失--2,296,924.13-5,111,280.46
  财务费用-58,758,941.51-114,417,669.76
  投资损失--27,436,415.66--17,787,444.36
  递延所得税-10,740,485.68--14,036,732.47
  其中:递延所得税资产减少-11,403,111.55--12,171,171.29
    递延所得税负债增加--662,625.87--1,865,561.18
  存货的减少-1,567,849,044.57--670,569,278.44
  经营性应收项目的减少-49,111,465.11-62,071,449.5
  经营性应付项目的增加--145,556,542.22--41,673,355.69
  现金的期末余额-1,254,623,826.49-514,802,240.02
  减:现金的期初余额-514,802,240.02-875,264,962.72
  减:现金等价物的期初余额---210,000,000
  现金及现金等价物的净增加额-739,821,586.47--570,462,722.7
公告日期2025-10-252025-08-262025-04-262025-04-08
审计意见(境内)标准无保留意见
TOP↑